Lenfoma
The lymph in the human body is actually complicated. Lymphoma is the fastest and the highest death in malignant tumors, because the lymphatic system of the human body has a great effect on the whole body. Once cancer cells appear, they will spread along the blood , It will be spread all over the body, which makes the treatment more difficult. Lymphoma targeted drugs are not completely free of side effects. The patients who use them must carefully observe their changes bit by bit and communicate with the doctor in time to be able to reduce.
Lenfoma uchun mo'ljallangan dorilar samarali bo'ladimi?
Early malignant lymphoma is actually lymphoma. When using targeted drugs, you must first perform genetic testing on the patient. When you find the corresponding targeted drugs, the targeted drugs have a direct killing effect on cancer cells. The advantage is that the damage to normal cells is not too great. Although there are side effects and drug resistance, it depends on the patient’s physical function, good physical fitness, high immunity, and the best therapeutic effect. Therefore, patients with lymphoma have to find ways to improve their immune function and enhance their resistance to tumors while using targeted drugs.
Targeted drug therapy affects the biological processes of cells, acting in different ways, preventing cancer cells from growing or dividing, causing cancer cells to die or using their own immune system to help the body kill cancer cells. Compared with chemotherapy, targeted drugs can act more precisely on lymphoma cells and reduce the impact of treatment on healthy cells, thereby reducing the side effects of treatment while being more effective.
Lenfoma uchun mo'ljallangan dorilar qanday?
Rituximab is the first targeted immunotherapy drug used to treat lymphoma. There are many other targeted drugs for the treatment of patients with lymphoma, some have been approved for marketing, and many drugs are still in clinical trials.
1. Surunkali limfotsitar leykemiya (CLL) / kichik limfotsitar leykemiya (SLL)
• Ibrutinib (Ibutinib, Imbruvica Eke)
• Idelalisib (Edelalis, Zydelig)
• Obinutuzumab (Atoruzumab, Gazyva)
• Rituximab (rituximab, Rituxan merova)
2. Teri (teri) T hujayrali lenfoma
• Brentuximab Vedotin (Bentuximab, Adcetris)
3. Diffuzli yirik B-hujayrali limfoma
• Rituximab (rituximab, Rituxan merova)
4. Follikulyar limfoma
• Idelalisib (Edelalis, Zydelig)
• Obinutuzumab (Atoruzumab, Gazyva)
• Rituximab (rituximab, Rituxan merova)
• Ibritumomab Tiuxetan (Timobizumab, Zevalin)
5. Klassik Xodgkin limfomasi
• Brentuximab Vedotin (Bentuximab, Adcetris)
• Nivolumab (Navuliu monoklonal antikor, Opdivo)
• Pembrolizumab (Pambrolizumab, Keytruda)
6. Birlamchi mediastinal B-hujayrali limfoma
• Rituximab (rituximab, Rituxan merova)
7. Mantiya hujayralari lenfomasi
• Bortezomib (bortezomib, Velcade Velcade)
• Ibrutinib (Ibutinib, Imbruvica Eke)
• Lenalidomid (Lenalidomid, Revlimid)
• Temsirolimus (sirolimus, Torisel uchun)
8. Tizimli anaplastik yirik hujayrali limfoma
• Brentuximab Vedotin (Bentuximab, Adcetris)
Lenfoma maqsadli dorilar narxining standart ko'rsatkichi yo'q
Lenfoma maqsadli dorilar asosan rituximab (rituximab in'ektsiyasi), davolash kursi 10,000 20,000 yoki XNUMX XNUMX ga yaqin. Xususiyat bemorning o'z holatiga bog'liq. Agar dori-darmonlarga qarshilik bo'lmasa, siz uni qabul qilishni davom ettirishingiz mumkin. Agar nojo'ya ta'sirlar yoki dori-darmonlarga qarshilik mavjud bo'lsa, siz to'xtatishingiz yoki boshqa davolash usullarini qo'llashingiz kerak. Shuning uchun narx belgilanmagan. O'zgarishlar bo'ladi.
Tanadagi toza qonni gemotopoez tizimi boshqaradi, limfa tizimi esa boshqaruvchidir. Hozir ko'plab elektron mahsulotlar mavjud va radiatsiya hamma joyda va istalgan vaqtda paydo bo'ladigan virusli infektsiyalar mavjud. Bu o'lik lenfoma rag'batlantiruvchi vositalar, hayotda lenfomalardan uzoqroq turishga ko'proq e'tibor berishingiz kerak, va limfomalar uchun mo'ljallangan dori-darmonlarni tanlash shunchalik tasodifiy emas.
